Evidence map›Paper›PMID 41384507›Full record

ArticleIUCrJ2026

Linear-scaling aspherical crystallographic refinement of proteins: a case study for crambin and rubredoxin.

Justin Bergmann, Florian Kleemiss, Joel Creutzberg, Esko Oksanen, Ulf Ryde

Abstract read
In one paragraph

Article in IUCrJ, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Towards routine accurate electron-density studies of biological macromolecules.Acta crystallographica. Section D, Structural biology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Justin BergmannDivision of Computational Chemistry, Chemical Centre, Lund University, PO Box 124, SE-221 00 Lund, Sweden.ORCID 0000-0001-9183-3857
Florian KleemissRWTH Aachen University, Institute of Inorganic Chemistry, Landoltweg 1a, 52074 Aachen, Germany.ORCID 0000-0002-3631-1535
Joel CreutzbergDivision of Computational Chemistry, Chemical Centre, Lund University, PO Box 124, SE-221 00 Lund, Sweden.
Esko OksanenDivision of Computational Chemistry, Chemical Centre, Lund University, PO Box 124, SE-221 00 Lund, Sweden.ORCID 0000-0002-1841-4813
Ulf RydeDivision of Computational Chemistry, Chemical Centre, Lund University, PO Box 124, SE-221 00 Lund, Sweden.ORCID 0000-0001-7653-8489

Funding

Deutsche Forschungsgemeinschaft KL-3500/1-1Tillväxtverket SREss3Vetenskapsrådet 2018-05003Vetenskapsrådet 2020-06176Vetenskapsrådet 2022-04978
6 · The paper itself

Abstract

Hirshfeld atom refinement (HAR) provides a more realistic interpretation of crystallographic data than the standard independent atom model (IAM) by using aspherical atomic form factors derived from quantum mechanical (QM) calculations. With this aspherical description, it is possible to obtain improved atomic positions, atomic displacement parameters and correct bond lengths even for hydrogen atoms. Unfortunately, HAR is computationally very demanding for larger molecules. Recently, we suggested how this can be solved by calculating aspherical atomic form factors for small overlapping fragments of the system, the fragHAR approach. Here, we have created a new implementation of fragHAR in Olex2 within the NoSpherA2 interface. We have also solved previous issues with hydrogen bonds by automatically extending the fragments with all hydrogen-bond acceptors. This implementation was successfully tested on three oligopeptides, demonstrating that fragHAR yields indistinguishable results in terms of atomic charge, residual density or R values compared with full HAR. Subsequently, fragHAR was applied to the proteins crambin and rubredoxin, with 843 and 1014 atoms, respectively, showing improved results in terms of e

Indexed as

Plant ProteinsRubredoxinsCrystallography, X-RayHydrogen BondingModels, MolecularProtein ConformationPlant ProteinsRubredoxinsfragHARHirshfeld atom refinementhydrogen atomspeptidesproteinsquantum crystallographystructure determination

Identifiers

PMID41384507
PMCPMC12809447

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.